No significant association was demonstrated between VEGF - B, VEGF - C, flt - 1, KDR, and flt - 4 with patient sex, patient age, or tumor size ( P greater than 0. 05).	"VEGF - B	52	60	Gene_or_gene_product"	"VEGF - C	62	70	Gene_or_gene_product"	"flt - 1	72	79	Gene_or_gene_product"	"KDR	81	84	Gene_or_gene_product"	"flt - 4	90	97	Gene_or_gene_product"	"patient	103	110	Organism"	"patient	116	123	Organism"	"tumor	132	137	Cancer"	"[{""token"": ""VEGF - B"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 1"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 4"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""patient"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""patient"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Cancer""}]"
The study shows that clear cell tumors are able to up - regulate angiogenic growth factor receptors more efficiently than chromophil ( papillary), that clear cell tumors can use pathways independent of VHL to regulate angiogenesis, and that this combined regulation may account for their more aggressive phenotype, which suggests that targeting VEGFR1 ( flt - l) may be particularly effective in these tumor types.	"clear cell tumors	21	38	Cancer"	"chromophil	122	132	Cancer"	"papillary	135	144	Cancer"	"clear cell tumors	152	169	Cancer"	"VHL	202	205	Gene_or_gene_product"	"VEGFR1	345	351	Gene_or_gene_product"	"flt - l	354	361	Gene_or_gene_product"	"tumor	402	407	Cancer"	"[{""token"": ""clear cell tumors"", ""start_span"": 21, ""end_span"": 38, ""type"": ""Cancer""}, {""token"": ""chromophil"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Cancer""}, {""token"": ""papillary"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Cancer""}, {""token"": ""clear cell tumors"", ""start_span"": 152, ""end_span"": 169, ""type"": ""Cancer""}, {""token"": ""VHL"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR1"", ""start_span"": 345, ""end_span"": 351, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - l"", ""start_span"": 354, ""end_span"": 361, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 402, ""end_span"": 407, ""type"": ""Cancer""}]"
The mammalian proto - oncogene Cbl and its cellular homologues in Caenorhabditis elegans ( Sli - 1) and Drosophila ( D - Cbl) are negative regulators of some growth factor receptor signaling pathways.	"mammalian	4	13	Organism"	"Cbl	31	34	Gene_or_gene_product"	"cellular	43	51	Cell"	"Caenorhabditis elegans	66	88	Organism"	"Sli - 1	91	98	Gene_or_gene_product"	"Drosophila	104	114	Organism"	"D - Cbl	117	124	Gene_or_gene_product"	"growth factor receptor	158	180	Gene_or_gene_product"	"[{""token"": ""mammalian"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""Cbl"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""Caenorhabditis elegans"", ""start_span"": 66, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""Sli - 1"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""Drosophila"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Organism""}, {""token"": ""D - Cbl"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""growth factor receptor"", ""start_span"": 158, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}]"
These results indicated that Crk plays a critical role in Rac1 - induced membrane ruffling and Rap1 - mediated nascent focal complex stabilization contributing to ephrin - B1 - induced human aortic endothelial cells migration.	"Crk	29	32	Gene_or_gene_product"	"Rac1	58	62	Gene_or_gene_product"	"membrane	73	81	Cellular_component"	"Rap1	95	99	Gene_or_gene_product"	"nascent focal complex	111	132	Cellular_component"	"ephrin - B1	163	174	Gene_or_gene_product"	"human	185	190	Organism"	"aortic endothelial cells	191	215	Cell"	"[{""token"": ""Crk"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rac1"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Cellular_component""}, {""token"": ""Rap1"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""nascent focal complex"", ""start_span"": 111, ""end_span"": 132, ""type"": ""Cellular_component""}, {""token"": ""ephrin - B1"", ""start_span"": 163, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 185, ""end_span"": 190, ""type"": ""Organism""}, {""token"": ""aortic endothelial cells"", ""start_span"": 191, ""end_span"": 215, ""type"": ""Cell""}]"
Binding of factor VIIa ( FVIIa) to its cellular receptor tissue factor ( TF) was previously shown to induce various intracellular signaling events, which were thought to be responsible for TF - mediated biologic effects, including angiogenesis, tumor metastasis, and restenosis.	"factor VIIa	11	22	Gene_or_gene_product"	"FVIIa	25	30	Gene_or_gene_product"	"cellular	39	47	Cell"	"tissue factor	57	70	Gene_or_gene_product"	"TF	73	75	Gene_or_gene_product"	"intracellular	116	129	Immaterial_anatomical_entity"	"TF	189	191	Gene_or_gene_product"	"tumor	245	250	Cancer"	"[{""token"": ""factor VIIa"", ""start_span"": 11, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""FVIIa"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""tissue factor"", ""start_span"": 57, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""TF"", ""start_span"": 73, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""intracellular"", ""start_span"": 116, ""end_span"": 129, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""TF"", ""start_span"": 189, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 245, ""end_span"": 250, ""type"": ""Cancer""}]"
Besides TGFbeta and RTK / Ras signaling, autocrine factors and Wnt -, Notch -, Hedgehog - and NF - kappaB - dependent pathways were found to contribute to EMT.	"TGFbeta	8	15	Gene_or_gene_product"	"RTK	20	23	Gene_or_gene_product"	"Ras	26	29	Gene_or_gene_product"	"Wnt	63	66	Gene_or_gene_product"	"Notch	70	75	Gene_or_gene_product"	"Hedgehog	79	87	Gene_or_gene_product"	"NF - kappaB	94	105	Gene_or_gene_product"	"EMT	155	158	Gene_or_gene_product"	"[{""token"": ""TGFbeta"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""RTK"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ras"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""Wnt"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hedgehog"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""EMT"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"
Given the dominant role of p21 in p53 cell cycle control, we crossed Trp53 ( 515C / 515C) mice onto a p21 - null background to determine whether p21 was required for maintaining chromosomal stability and delaying tumor onset.	"p21	27	30	Gene_or_gene_product"	"p53	34	37	Gene_or_gene_product"	"cell	38	42	Cell"	"Trp53	69	74	Gene_or_gene_product"	"p21	102	105	Gene_or_gene_product"	"p21	145	148	Gene_or_gene_product"	"chromosomal	178	189	Cellular_component"	"tumor	213	218	Cancer"	"[{""token"": ""p21"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""Trp53"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosomal"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Cancer""}]"
Cytogenetic examination of Trp53 ( 515C / 515C) p21 ( - / -) sarcomas and lymphomas revealed aneuploidy and chromosomal aberrations that were absent in Trp53 ( 515C / 515C) malignancies.	"Trp53	27	32	Gene_or_gene_product"	"p21	48	51	Gene_or_gene_product"	"sarcomas	61	69	Cancer"	"lymphomas	74	83	Cancer"	"aneuploidy	93	103	Pathological_formation"	"chromosomal aberrations	108	131	Pathological_formation"	"Trp53	152	157	Gene_or_gene_product"	"malignancies	173	185	Cancer"	"[{""token"": ""Trp53"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""sarcomas"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""lymphomas"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Cancer""}, {""token"": ""aneuploidy"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Pathological_formation""}, {""token"": ""chromosomal aberrations"", ""start_span"": 108, ""end_span"": 131, ""type"": ""Pathological_formation""}, {""token"": ""Trp53"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignancies"", ""start_span"": 173, ""end_span"": 185, ""type"": ""Cancer""}]"
Induction of gelatinases ( matrix metalloproteinase 2 and 9), the serine protease tissue plasminogen activator and plasmin by DCN transfection in MCE cells leads to extracellular proteolysis and to release of matrix - bound VEGF and activation of angiogenesis.	"matrix metalloproteinase 2	27	53	Gene_or_gene_product"	"9	58	59	Gene_or_gene_product"	"tissue plasminogen activator	82	110	Gene_or_gene_product"	"plasmin	115	122	Gene_or_gene_product"	"DCN	126	129	Gene_or_gene_product"	"MCE cells	146	155	Cell"	"extracellular	165	178	Immaterial_anatomical_entity"	"VEGF	224	228	Gene_or_gene_product"	"[{""token"": ""matrix metalloproteinase 2"", ""start_span"": 27, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""9"", ""start_span"": 58, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue plasminogen activator"", ""start_span"": 82, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasmin"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCN"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCE cells"", ""start_span"": 146, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""extracellular"", ""start_span"": 165, ""end_span"": 178, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""VEGF"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Gene_or_gene_product""}]"
Cediranib ( RECENTIN; AZD2171) is an inhibitor of VEGF signaling that has been shown in experimental models to prevent VEGF - A - induced angiogenesis and primary tumor growth, yet the effects of cediranib on VEGF receptor ( VEGFR) - 3 - mediated endothelial cell function and lymphangiogenesis are unknown.	"Cediranib	0	9	Chemical"	"RECENTIN	12	20	Chemical"	"AZD2171	22	29	Chemical"	"VEGF	50	54	Gene_or_gene_product"	"VEGF - A	119	127	Gene_or_gene_product"	"tumor	163	168	Cancer"	"cediranib	196	205	Chemical"	"endothelial cell	247	263	Cell"	"[{""token"": ""Cediranib"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""RECENTIN"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Chemical""}, {""token"": ""AZD2171"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - A"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Cancer""}, {""token"": ""cediranib"", ""start_span"": 196, ""end_span"": 205, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 247, ""end_span"": 263, ""type"": ""Cell""}]"
Cediranib ( 6 mg / kg / day) also blocked angiogenesis and lymphangiogenesis induced by adenoviruses expressing VEGF - A or VEGF - C and compromised the blood and lymphatic vasculatures of VEGF - C - expressing tumors.	"Cediranib	0	9	Chemical"	"adenoviruses	88	100	Organism"	"VEGF - A	112	120	Gene_or_gene_product"	"VEGF - C	124	132	Gene_or_gene_product"	"blood	153	158	Organism_substance"	"lymphatic vasculatures	163	185	Multi"	"VEGF - C	189	197	Gene_or_gene_product"	"tumors	211	217	Cancer"	"[{""token"": ""Cediranib"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""adenoviruses"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Organism""}, {""token"": ""VEGF - A"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Organism_substance""}, {""token"": ""lymphatic vasculatures"", ""start_span"": 163, ""end_span"": 185, ""type"": ""Multi""}, {""token"": ""VEGF - C"", ""start_span"": 189, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 211, ""end_span"": 217, ""type"": ""Cancer""}]"
Systemic administration of VEGF or LPS in adult mice resulted in cyclosporine A - sensitive reactivation of the DSCR1s promoter and endogenous gene expression in a subset of organs, including the heart and brain.	"VEGF	27	31	Gene_or_gene_product"	"LPS	35	38	Chemical"	"mice	48	52	Organism"	"cyclosporine A	65	79	Chemical"	"DSCR1s	112	118	Gene_or_gene_product"	"organs	174	180	Organ"	"heart	196	201	Organ"	"brain	206	211	Organ"	"[{""token"": ""VEGF"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""LPS"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""cyclosporine A"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""DSCR1s"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""organs"", ""start_span"": 174, ""end_span"": 180, ""type"": ""Organ""}, {""token"": ""heart"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Organ""}, {""token"": ""brain"", ""start_span"": 206, ""end_span"": 211, ""type"": ""Organ""}]"
Compared with CSC - low tumors, CSC - high tumors exhibited increased microvessel density and blood perfusion and induced increased mobilization and tumor recruitment of bone marrow - derived endothelial progenitor cells ( EPC).	"CSC - low tumors	14	30	Cancer"	"CSC - high tumors	32	49	Cancer"	"microvessel	70	81	Tissue"	"blood	94	99	Organism_substance"	"tumor	149	154	Cancer"	"bone marrow	170	181	Multi"	"endothelial progenitor cells	192	220	Cell"	"EPC	223	226	Cell"	"[{""token"": ""CSC - low tumors"", ""start_span"": 14, ""end_span"": 30, ""type"": ""Cancer""}, {""token"": ""CSC - high tumors"", ""start_span"": 32, ""end_span"": 49, ""type"": ""Cancer""}, {""token"": ""microvessel"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Tissue""}, {""token"": ""blood"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Organism_substance""}, {""token"": ""tumor"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Cancer""}, {""token"": ""bone marrow"", ""start_span"": 170, ""end_span"": 181, ""type"": ""Multi""}, {""token"": ""endothelial progenitor cells"", ""start_span"": 192, ""end_span"": 220, ""type"": ""Cell""}, {""token"": ""EPC"", ""start_span"": 223, ""end_span"": 226, ""type"": ""Cell""}]"
BPDE treatment caused induction of both AP - 1 and NF - kappaB activity as determined by luciferase reporter assay and only NF - kappaB induction in response to BPDE was significantly attenuated by TSC phenolic fraction whereas AP - 1 induction remains unaltered.	"BPDE	0	4	Chemical"	"AP - 1	40	46	Gene_or_gene_product"	"NF - kappaB	51	62	Gene_or_gene_product"	"luciferase	89	99	Gene_or_gene_product"	"NF - kappaB	124	135	Gene_or_gene_product"	"BPDE	161	165	Chemical"	"TSC phenolic fraction	198	219	Chemical"	"AP - 1	228	234	Gene_or_gene_product"	"[{""token"": ""BPDE"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""AP - 1"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""BPDE"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Chemical""}, {""token"": ""TSC phenolic fraction"", ""start_span"": 198, ""end_span"": 219, ""type"": ""Chemical""}, {""token"": ""AP - 1"", ""start_span"": 228, ""end_span"": 234, ""type"": ""Gene_or_gene_product""}]"
In this study, the aim was to investigate the effect of phenolic acids found abundantly in vegetables, i. e. gallic acid ( GA), caffeic acid ( CA) and protocatechuic acid ( PCA), on the inhibition of gastric adenocarcinoma ( AGS) cell metastasis.	"phenolic acids	56	70	Chemical"	"vegetables	91	101	Organism_subdivision"	"gallic acid	109	120	Chemical"	"GA	123	125	Chemical"	"caffeic acid	128	140	Chemical"	"CA	143	145	Chemical"	"protocatechuic acid	151	170	Chemical"	"PCA	173	176	Chemical"	"[{""token"": ""phenolic acids"", ""start_span"": 56, ""end_span"": 70, ""type"": ""Chemical""}, {""token"": ""vegetables"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Organism_subdivision""}, {""token"": ""gallic acid"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Chemical""}, {""token"": ""GA"", ""start_span"": 123, ""end_span"": 125, ""type"": ""Chemical""}, {""token"": ""caffeic acid"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Chemical""}, {""token"": ""CA"", ""start_span"": 143, ""end_span"": 145, ""type"": ""Chemical""}, {""token"": ""protocatechuic acid"", ""start_span"": 151, ""end_span"": 170, ""type"": ""Chemical""}, {""token"": ""PCA"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Chemical""}]"
The quaternary benzo [ c] phenanthridine alkaloid sanguinarine inhibits the proliferation of cancerous cells from different origins, including lung, breast, pancreatic and colon, but nothing is known of its effects on osteosarcoma, a primary malignant bone tumour.	"sanguinarine	50	62	Chemical"	"cancerous cells	93	108	Cell"	"lung	143	147	Organ"	"breast	149	155	Organism_subdivision"	"pancreatic	157	167	Organ"	"colon	172	177	Organ"	"osteosarcoma	218	230	Cancer"	"primary malignant bone tumour	234	263	Cancer"	"[{""token"": ""sanguinarine"", ""start_span"": 50, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""cancerous cells"", ""start_span"": 93, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""lung"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Organ""}, {""token"": ""breast"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Organism_subdivision""}, {""token"": ""pancreatic"", ""start_span"": 157, ""end_span"": 167, ""type"": ""Organ""}, {""token"": ""colon"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Organ""}, {""token"": ""osteosarcoma"", ""start_span"": 218, ""end_span"": 230, ""type"": ""Cancer""}, {""token"": ""primary malignant bone tumour"", ""start_span"": 234, ""end_span"": 263, ""type"": ""Cancer""}]"
The development and progression of colorectal cancer ( CRC) is a multi - step process, and the Wnt pathways with its two molecular gladiators adenomatous polyposis coli ( APC) and beta - catenin plays an important role in transforming a normal tissue into a malignant one.	"colorectal cancer	35	52	Cancer"	"CRC	55	58	Cancer"	"Wnt	95	98	Gene_or_gene_product"	"adenomatous polyposis coli	142	168	Gene_or_gene_product"	"APC	171	174	Gene_or_gene_product"	"beta - catenin	180	194	Gene_or_gene_product"	"normal tissue	237	250	Tissue"	"malignant one	258	271	Cancer"	"[{""token"": ""colorectal cancer"", ""start_span"": 35, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""CRC"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""Wnt"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenomatous polyposis coli"", ""start_span"": 142, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""APC"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 180, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}, {""token"": ""normal tissue"", ""start_span"": 237, ""end_span"": 250, ""type"": ""Tissue""}, {""token"": ""malignant one"", ""start_span"": 258, ""end_span"": 271, ""type"": ""Cancer""}]"
The results in steady state reveal that both substrates glucose and glutamine are continuously wasted by tumour cells, excreting two moles of lactate per mol of glucose and one mol of glutamate and ammonia per mol of glutamine consumed into the medium.	"glucose	56	63	Chemical"	"glutamine	68	77	Amino_acid"	"tumour cells	105	117	Cell"	"lactate	142	149	Chemical"	"glucose	161	168	Chemical"	"glutamate	184	193	Amino_acid"	"ammonia	198	205	Chemical"	"glutamine	217	226	Amino_acid"	"[{""token"": ""glucose"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""glutamine"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Amino_acid""}, {""token"": ""tumour cells"", ""start_span"": 105, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""lactate"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Chemical""}, {""token"": ""glutamate"", ""start_span"": 184, ""end_span"": 193, ""type"": ""Amino_acid""}, {""token"": ""ammonia"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Chemical""}, {""token"": ""glutamine"", ""start_span"": 217, ""end_span"": 226, ""type"": ""Amino_acid""}]"
The amplification and overexpression of the HER - 2 / neu proto - oncogene, which encodes the tyrosine kinase receptor p185neu, have been observed frequently in tumors from human breast cancer patients and are correlated with poor prognosis.	"HER - 2	44	51	Gene_or_gene_product"	"neu	54	57	Gene_or_gene_product"	"tyrosine	94	102	Amino_acid"	"p185neu	119	126	Gene_or_gene_product"	"tumors	161	167	Cancer"	"human	173	178	Organism"	"breast cancer	179	192	Cancer"	"patients	193	201	Organism"	"[{""token"": ""HER - 2"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Amino_acid""}, {""token"": ""p185neu"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 179, ""end_span"": 192, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 193, ""end_span"": 201, ""type"": ""Organism""}]"
Emodin also induced differentiation of HER - 2 / neu - overexpressing breast cancer cells by exhibiting a morphological maturation property of large lacy nuclei surrounded by sizable flat cytoplasm and by showing a measurable production of large lipid droplets, which is a marker of mature breast cells.	"Emodin	0	6	Chemical"	"HER - 2	39	46	Gene_or_gene_product"	"neu	49	52	Gene_or_gene_product"	"breast cancer cells	70	89	Cell"	"nuclei	154	160	Cellular_component"	"flat cytoplasm	183	197	Organism_substance"	"lipid	246	251	Chemical"	"mature breast cells	283	302	Cell"	"[{""token"": ""Emodin"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""HER - 2"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 70, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""nuclei"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Cellular_component""}, {""token"": ""flat cytoplasm"", ""start_span"": 183, ""end_span"": 197, ""type"": ""Organism_substance""}, {""token"": ""lipid"", ""start_span"": 246, ""end_span"": 251, ""type"": ""Chemical""}, {""token"": ""mature breast cells"", ""start_span"": 283, ""end_span"": 302, ""type"": ""Cell""}]"
The epidermal growth factor receptor ( EGF - R, c - erbB1), Her - 2 / neu ( c - erbB2), and c - erbB3 are members of the erbB - family.	"epidermal growth factor receptor	4	36	Gene_or_gene_product"	"EGF - R	39	46	Gene_or_gene_product"	"c - erbB1	48	57	Gene_or_gene_product"	"Her - 2	60	67	Gene_or_gene_product"	"neu	70	73	Gene_or_gene_product"	"c - erbB2	76	85	Gene_or_gene_product"	"c - erbB3	92	101	Gene_or_gene_product"	"erbB	121	125	Gene_or_gene_product"	"[{""token"": ""epidermal growth factor receptor"", ""start_span"": 4, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF - R"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - erbB1"", ""start_span"": 48, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""Her - 2"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - erbB2"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - erbB3"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""erbB"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}]"
Since the vessels of normal non - neoplastic human tissues, e. g. of intestine or lymphatic organs, have few somatostatin receptors, the increased somatostatin receptor expression in peritumoral vessels observed in this study may be linked to the neoplastic process itself.	"vessels	10	17	Multi"	"human	45	50	Organism"	"tissues	51	58	Tissue"	"intestine	69	78	Organ"	"lymphatic organs	82	98	Organ"	"somatostatin receptors	109	131	Gene_or_gene_product"	"somatostatin receptor	147	168	Gene_or_gene_product"	"peritumoral vessels	183	202	Multi"	"[{""token"": ""vessels"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""tissues"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Tissue""}, {""token"": ""intestine"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Organ""}, {""token"": ""lymphatic organs"", ""start_span"": 82, ""end_span"": 98, ""type"": ""Organ""}, {""token"": ""somatostatin receptors"", ""start_span"": 109, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""somatostatin receptor"", ""start_span"": 147, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""peritumoral vessels"", ""start_span"": 183, ""end_span"": 202, ""type"": ""Multi""}]"
Syndecan - 1 is a cell surface proteoglycan that has been implicated in a number of cellular functions including cell - cell adhesion, cell - matrix anchorage and growth factor presentation for signalling receptors.	"Syndecan - 1	0	12	Gene_or_gene_product"	"cell surface	18	30	Cellular_component"	"cellular	84	92	Cell"	"cell	113	117	Cell"	"cell	120	124	Cell"	"cell	135	139	Cell"	"matrix	142	148	Cellular_component"	"growth factor	163	176	Gene_or_gene_product"	"[{""token"": ""Syndecan - 1"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell surface"", ""start_span"": 18, ""end_span"": 30, ""type"": ""Cellular_component""}, {""token"": ""cellular"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 142, ""end_span"": 148, ""type"": ""Cellular_component""}, {""token"": ""growth factor"", ""start_span"": 163, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}]"
In transfected MDCK canine kidney epithelial cells, 5T4 over - expression also results in increased motility, but disruption of cell - cell contacts, either by culturing cells in low calcium medium or by addition of HGF / SF, is needed.	"MDCK canine kidney epithelial cells	15	50	Cell"	"5T4	52	55	Gene_or_gene_product"	"cell	128	132	Cell"	"cell	135	139	Cell"	"cells	170	175	Cell"	"calcium	183	190	Chemical"	"HGF	216	219	Gene_or_gene_product"	"SF	222	224	Gene_or_gene_product"	"[{""token"": ""MDCK canine kidney epithelial cells"", ""start_span"": 15, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""5T4"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Cell""}, {""token"": ""calcium"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Chemical""}, {""token"": ""HGF"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}, {""token"": ""SF"", ""start_span"": 222, ""end_span"": 224, ""type"": ""Gene_or_gene_product""}]"
Focal adhesion kinase ( pp125FAK or FAK) is a protein tyrosine kinase which is associated with intracellular signalling cascades which are initiated when the integrin family of cell adhesion molecules engage extracellular matrix molecules.	"Focal adhesion kinase	0	21	Gene_or_gene_product"	"pp125FAK	24	32	Gene_or_gene_product"	"FAK	36	39	Gene_or_gene_product"	"protein tyrosine kinase	46	69	Gene_or_gene_product"	"intracellular	95	108	Immaterial_anatomical_entity"	"integrin	158	166	Gene_or_gene_product"	"cell adhesion molecules	177	200	Gene_or_gene_product"	"extracellular matrix	208	228	Cellular_component"	"[{""token"": ""Focal adhesion kinase"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""pp125FAK"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""FAK"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""protein tyrosine kinase"", ""start_span"": 46, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""intracellular"", ""start_span"": 95, ""end_span"": 108, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""integrin"", ""start_span"": 158, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell adhesion molecules"", ""start_span"": 177, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular matrix"", ""start_span"": 208, ""end_span"": 228, ""type"": ""Cellular_component""}]"
